Serum ferritin and hepatic glutathione concentrations in chronic hepatitis C patients related to the hepatitis C virus genotype

Journal of Hepatology

Volumn 30, Issue 5, 1999, Pages 774-782

  Barbaro, Giuseppe ^a   Lorenzo, Gabriella Di ^a   Ribersani, Michela ^a   Soldini, Maurizio ^a   Giancaspro, Giuseppe ^a   Bellomo, Giorgio ^b   Belloni, Giancarlo ^c   Grisorio, Benvenuto ^d   Barbarini, Giorgio ^c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d GENERAL HOSPITAL   (Italy)

Author keywords

Chronic hepatitis C; Ferritin; Glutathione; HCV genotypes

Indexed keywords

FERRITIN; GLUTATHIONE;

ADULT; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOTOXICITY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 0033067273     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80128-7     Document Type: Article

References (37)

1. Di Bisceglie A, Axiotis C, Hoffnagle J, Bacon B. Measurement of iron status in patients with chronic hepatitis. Gastroenterology. 102:1992;140-146.
2. Farinati F, Cardin R, De Maria N, Della Libera G, Marafin C, Lecis E, et al. Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J Hepatol. 22:1995;449-456.
3. Arber N, Konikoff FM, Moshkowitz M, Baratz M, Hallak A, Santo M, et al. Increased serum iron and iron saturation without liver iron accumulation distinguish chronic hepatitis C from other chronic liver diseases. Dig Dis Sci. 39:1994;2656-2659.
4. Arber N, Moshkowitz M, Konikoff F, Halpern Z, Hallak A, Santo M, et al. Elevated serum iron predicts poor response to interferon treatment in patients with chronic HCV infection. Dig Dis Sci. 40:1995;2431-2433.
5. Suarez M, Beloqui O, Ferrer JV, Gil B, Qian C, Garcia N, et al. Glutatione depletion in chronic hepatitis C. Int Hepatol Commun. 1:1993;215-221.
6. Beloqui O, Prieto J, Suarez M, Gil B, Qian CH, Garcia N, et al. N-acetyl-cysteine enhances the response to interferon alfa in chronic hepatitis C: a pilot study. J Interf Res. 13:1993;279-282.
7. Barbaro G, Di Lorenzo G, Soldini M, Parotto S, Bellomo G, Belloni G, et al. Hepatic glutathione deficiency in chronic hepatitis C: quantitative evaluation in patients who are HIV positive and HIV negative and correlations with plasmatic and lymphocytic concentrations and with the activity of the liver disease. Am J Gastroenterol. 91:1996;2569-2573.
8. Barbaro G, Di Lorenzo G, Soldini M, Bellomo G, Belloni G, Grisorio B, et al. Vagal system impairment in human immunodeficiency virus-positive patients with chronic hepatitis C: does hepatic glutathione deficiency have a pathogenetic role? Scand J Gastroenterol. 32:1997;1261-1266.
9. Okamoto H, Okada S, Sugiyama Y, Yutsomoto S, Tanak T, Yoshizawa H, et al. The 5′ terminal sequence of the hepatitis C virus genome. Jpn J Exp Med. 60:1990;167-177.
10. Shindo M, Di Bisceglie AM, Cheung L, Shih JW, Feinstone SM, Cristiano K, et al. Decrease in hepatitis C virus RNA during alpha-interferon therapy for chronic hepatitis C. Ann Intern Med. 115:1990;700-704.
11. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
12. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol. 73:1992;673-679.
13. Okamoto H, Tokita H, Sakamoto M, Horikita M, Iizuka H, Mishiro S. Characterization of the genomic sequence of the type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. J Gen Virol. 75:1994;629-635.
14. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1:1981;431-435.
15. Deugnier Y, Loreal O, Turlin B, Guyader D, Jouanolle H, Moirand R, et al. Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations. Gastroenterology. 102:1992;2050-2059.
16. Reed DJ, Babson JR, Beatley PW, Brodie AE, Ellis WW, Potter DW. High Performance Liquid Cromatography analysis of nanomole levels of glutathione, glutathione disulfide and related thiols and disulfides. Anal Biochem. 106:1980;55-62.
17. Lowry OH, Rosenbrough RJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 193:1951;265-275.
18. Brigelius R, Muckel C, Akerboom TP, Sies H. Identification and qualification of glutathione in hepatic protein mixed disulfides and its relationship to glutathione disulfide. Biochem Pharmacol. 32:1983;2529-2534.
19. Masugi F, Nakamura T. Measurement of thiobarbituric acid value in liver homogenate solubilized with sodium dodecyl sulphate and variation of the values affected by vitamin E and drugs. Vitamins. 51:1977;21-29.
20. Poli G, Biasi F, Chiarpotto E, Dianzani MU, De Luca A, Esterbauer H. Lipid peroxidation in human disease: evidence of red cell oxidative stress after circulatory shock. Free Rad Biol Med. 6:1989;167-170.
21. Esterbauer H, Lang J, Zadravec S, Slater TF. Detection of malonaldehyde by high-performance liquid chromatography. Meth Enzymol. 105:1984;319-325.
22. Misefari A, Jirillo E. Immunologia. 1991;272 Società Editrice Scientifica, Napoli.
23. Armitage P, Berry G. Statistical Methods in Medical Research, 3rd ed. 1994;453-460 Blackwell Scientific, Oxford.
24. Hann HW, Kim CY, London T, Blumberg B. Increased serum ferritin in chronic liver disease: a risk factor for primary hepatocellular carcinoma. Int J Cancer. 43:1989;376-379.
25. Deleve LD, Kaplowitz N. Importance and regulation of hepatic glutathione. Semin Liver Dis. 10:1990;251-266.
26. Bacon BR, Britton RS. Hepatic injury in chronic iron overload: role of lipid peroxidation. Chem Biol Interact. 70:1989;183-226.
27. Bacon BR, Park CH, Brittenham GM, O'Neill R, Tavill AS. Hepatic mitochondrial oxidative metabolism in rats with chronic dietary iron overload. Hepatology. 5:1985;789-797.
28. Borysiewicz LK, Graham S, Sissons JGP. Human natural killer cells lysis of virus-infected cells. Relationship to expression of the transferrin receptor. Eur J Immunol. 16:1986;4051-4055.
29. Van Thiel DH, Colantoni A, De Maria N. Hepatic iron, serum indices of iron status and chronic hepatitis C: activity, stage and response to therapy. Ital J Gastroenterol. 30:1998;402-404.
30. Staal FJT, Ela SW, Roederer M, Anderson MT, Herzenberg LA, Herzenberg LA. Glutathione deficiency and human immunodeficiency virus infection. Lancet. 339:1992;909-912.
31. Halliwell B, Gutteridge JMC, editors. Free radicals, ageing and disease. Halliwell B, Gutteridge JMC editors. Free Radicals in Biology and Medicine. 1991;416-508 Oxford University Press, New York.
32. Izumi N, Enomoto N, Uchihara M, Murakami T, Ono K, Noguchi O, et al. Hepatic iron contents and response to interferonalpha in patients with chronic hepatitis C. Relationship to genotypes of hepatitis C virus. Dig Dis Sci. 41:1996;989-994.
33. Vendemiale G, Altomare E, Trizio T, Le Grazie C, Di Padova C, Salerno MT, et al. Effects of oral S-adenosyl-L-methionine on hepatic glutathione in patients with liver disease. Scand J Gastroenterol. 24:1989;407-415.
34. Loguercio C, Clot P, Albano E, Argenzio F, Grella A, De Girolamo V, et al. Free radicals and not acetaldehyde influence the circulating levels of glutathione after acute or chronic alcohol abuse: in vivo and in vitro studies. Ital J Gastroenterol Hepatol. 29:1997;168-173.
35. Hayashi H, Takikawa T, Nishimura N, Yano M, Isomura T, Sakamoto N. Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron. Am J Gastroenterol. 89:1994;986-988.
36. Van Thiel DH, Friedlander L, Molloy PJ, Kania RJ, Fagiuoli S, Wright HL, et al. Retreatment of hepatitis C interferon non-responders with larger doses of interferon with and without phlebotomy. Hepato-Gastroenterology. 43:1996;1557-1561.
37. Tsai NCS, Zuckerman E, Han SH, Goad K, Redeker AG, Fong TL. Effect of iron depletion on long-term response to interferon-α in patients with chronic hepatitis C who previously did not respond to interferon therapy. Am J Gastroenterol. 92:1997;1831-1833.